Company news

Elutia, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Elutia to Report Third Quarter 2024 Financial Results on Thursday, November 14, 2024

October 28, 2024

Elutia to Present at the LD Micro Main Event XVII Conference on Wednesday, October 30

October 22, 2024

Elutia Announces New Peer Reviewed Publication Highlighting the Robustness of EluPro™, Company’s Antibiotic-Eluting BioEnvelope for Implantable Devices

September 17, 2024

Elutia Announces First Patient Implant of EluPro™, the World’s First Drug-Eluting BioEnvelope for Cardiac Pacemakers and Neurostimulators

September 4, 2024

Elutia Announces Second Quarter 2024 Results

August 6, 2024

Elutia Announces Full Exercise of Warrants Generating $15.7 Million in Gross Proceeds

July 31, 2024

Elutia Appoints Ryan Marques, Ph.D., MBA as Vice President of Operations

July 30, 2024

Elutia Announces FDA Clearance of EluPro®: The First Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Implantable Cardiac Pacemakers and Defibrillators

June 16, 2024

Elutia Announces $13.26 Million Registered Direct Offering

June 16, 2024

Elutia Announces First Quarter 2024 Results: SimpliDerm® Sales Increase 55%, CanGaroo®RM on Track for Second Quarter 2024 FDA Clearance

May 8, 2024

Elutia to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024

May 1, 2024

Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM® Clearance Decision in First Half of 2024

March 6, 2024

Elutia's CanGarooRM: Pioneering Drug-Eluting Biologic for Secure Medical Implants

February 19, 2024

Elutia Submits CanGarooRM® Antibiotic-Eluting Biomatrix for FDA Clearance

December 17, 2023

Elutia Reports 26% Year-Over-Year Sales Growth of Proprietary Products and Strengthened Balance Sheet in Third Quarter 2023 Financial Results

November 12, 2023

Elutia Completes Divestiture of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million

November 8, 2023

Elutia to Report Third Quarter 2023 Financial Results on Monday, November 13, 2023

November 5, 2023

Elutia Announces Private Placement for Proceeds Up to $26 Million

September 18, 2023

Elutia Announces Sale of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million

September 17, 2023

← Newer news releases

Calls

The 5 newest of 24 calls. Every call is listed under its year.

Decks

The 5 newest of 9 decks. Every deck is listed under its year.